NASDAQ:CNTA

Centessa Pharmaceuticals Stock Forecast

etoro logo Buy CNTA
*Your capital is at risk
$39.85
-0.0500 (-0.125%)
At Close: Jun 03, 2026
AI Analysis AI Analysis of CNTA AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CNTA to Watchlist?
Some Reasons Why To Add CNTA:
  • +218.0% price growth over the last year
  • +68.2% YTD performance
  • Low bankruptcy risk (Altman Z-Score: 20.42)
PDF

Weaker technical forecast for Centessa Pharmaceuticals Limited as stock downgraded to Buy Candidate
(Updated on Jun 03, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Mar 24, 2026 Gain 42.88%

The Centessa Pharmaceuticals Limited stock price fell by -0.125% on the last day (Wednesday, 3rd Jun 2026) from $39.90 to $39.85. During the last trading day the stock fluctuated 0.352% from a day low at $39.78 to a day high of $39.92. The price has risen in 6 of the last 10 days and is up by 0.38% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -278 thousand shares and in total, 840 thousand shares were bought and sold for approximately $33.46 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 47.47% during the next 3 months and, with a 90% probability hold a price between $56.01 and $69.50 at the end of this 3-month period.

CNTA Signals & Forecast

The Centessa Pharmaceuticals Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $39.82 and $39.63. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, June 02, 2026, and so far it has fallen -0.125%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Centessa Pharmaceuticals Limited stock

Centessa Pharmaceuticals Limited finds support from accumulated volume at $39.72 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.140 between high and low, or 0.352%. For the last week the stock has had daily average volatility of 0.405%.

Our recommended stop-loss: $38.40 (-3.63%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (CNTA) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Centessa Pharmaceuticals Limited to open at $39.85, and during the day (based on 14 day Average True Range), to move between $39.73 and $39.97, which gives a possible trading interval of +/-$0.231 (+/-0.58%) up or down from last closing price. If Centessa Pharmaceuticals Limited takes out the full calculated possible swing range there will be an estimated 0.58% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $39.86 (0.03%) than the support at $39.72 (0.33%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Centessa Pharmaceuticals Limited stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Centessa Pharmaceuticals Limited stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

Current score: 2.742 Buy Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $39.85 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CNTA Performance

Trading levels for CNTA

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 39.99 0.351%
R2 39.94 0.217%
R1 39.90 0.134%
Price 39.85
S1 39.80 -0.134%
S2 39.76 -0.217%
S3 39.71 -0.351%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 39.90 0.125%
R1 39.86 0.0251%
Price 39.85
S1 39.72 -0.326%
S2 39.61 -0.602%
S3 39.59 -0.652%

FAQ

What is the symbol for Centessa Pharmaceuticals Limited Stock and on which exchange is it traded?
The symbol for Centessa Pharmaceuticals Limited is CNTA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Centessa Pharmaceuticals Limited Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Centessa Pharmaceuticals Limited stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

How to buy Centessa Pharmaceuticals Limited Stock?
Centessa Pharmaceuticals Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Centessa Pharmaceuticals Limited Stock.

What's the current price of Centessa Pharmaceuticals Limited Stock?
As of the end of day on the Jun 03, 2026, the price of an Centessa Pharmaceuticals Limited (CNTA) share was $39.85.

What is the 52-week high and low for Centessa Pharmaceuticals Limited Stock?
The 52-week high for Centessa Pharmaceuticals Limited Stock is $40.25 and the 52-week low is $10.95.

What is the market capitalization of Centessa Pharmaceuticals Limited Stock?
As of the Jun 03, 2026, the market capitalization of Centessa Pharmaceuticals Limited is 6.166B.

When is the next earnings date for Centessa Pharmaceuticals Limited?
The upcoming earnings date for Centessa Pharmaceuticals Limited is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT CENTESSA PHARMACEUTICALS LIMITED
Centessa Pharmaceuticals
Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; and SerpinPC, an activated protein C inhibitor, which is in Phase IIa clinical development for the treatm...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE